24.03.2026

What Requirements must a Responsible Person for GDP meet?

The Responsible Person (RP) plays a central role within medicinal product wholesale distribution and across all GDP-relevant distribution activities within the scope of the wholesale distribution authorisation.

The RP ensures that the requirements of Good Distribution Practice (GDP) are complied with and that the quality, safety, and integrity of medicinal products are maintained throughout all activities performed under the wholesale authorisation.

With the increasing complexity of global supply chains, intensified regulatory focus on the prevention of falsified medicines, temperature-controlled supply chains, serialization and verification obligations, as well as a growing number of inspections, the importance of this function has significantly increased in recent years.

The RP is not merely a formal position; rather, the individual must be genuinely authorised and able to take and enforce quality-related decisions independently of commercial pressures.

Regulatory Framework

Unlike the Qualified Person (QP) in the GMP environment, the formal educational requirements for the GDP Responsible Person are not exhaustively defined by legislation.

The primary regulatory basis in the European Union is the “Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01)”.

Chapter 2.2 (Responsible Person) states: "The wholesale distributor must designate a person as responsible person. The responsible person should meet the qualifications and all conditions provided for by the legislation of the Member State concerned. A degree in pharmacy is desirable. The responsible person should have appropriate competence and experience as well as knowledge of and training in GDP."

While the EU GDP Guidelines provide the regulatory framework, the specific qualification requirements and administrative expectations may differ between EU Member States.

National legislation and competent authorities may interpret and apply these requirements differently. Therefore, comapnies must always assess the applicable national provisions in addition to the EU GDP Guidelines.

By way of example, in Germany the provisions of Section 52a of the German Medicinal Products Act (Arzneimittelgesetz – AMG) apply. A wholesale distribution authorisation is required for the wholesale distribution of medicinal products. Pursuant to Section 52a (2) No. 3 AMG, the applicant must designate a Responsible Person possessing the necessary expertise (Sachkenntnis) for the activity. However, the Act does not precisely define the scope and content of this expertise.

This legal wording was further clarified by a judgment of the German Federal Administrative Court (Bundesverwaltungsgericht, judgment of 5 November 2020 – 3 C 7.19). The Court clarified that:

• Pharmaceutical knowledge equivalent to formal pharmaceutical vocational training is not mandatory.
• The required expertise may be acquired through practical experience, particularly through activities performed under the guidance and supervision of a Responsible Person.
• It is decisive that the Responsible Person possesses sufficient knowledge regarding the handling of the specific medicinal products distributed.
• The requirements are case-specific and depend on the type, scope, and risk profile of the respective wholesale operation.

The Court further emphasised that the Responsible Person is not required to personally conduct complex pharmaceutical-scientific risk assessments. However, the RP must be capable of obtaining expert assessments, understanding them, and evaluating their practical implementation.

This example illustrates that, although the EU GDP Guidelines establish a common regulatory baseline, national interpretation and jurisprudence may shape the concrete qualification profile required in a given Member State.

Professional and Personal Requirements of the Responsible Person for GDP

Although no specific academic degree is uniformly mandated across the EU, the following qualifications have proven appropriate in practice:

• Scientific, pharmaceutical, or technical background (e.g. pharmacy, chemistry, biology, logistics, engineering)
• In-depth knowledge of GDP requirements
• Understanding of related regulatory frameworks such as GMP, pharmaceutical legislation, and falsified medicines legislation
• Experience in medicinal product wholesale distribution, logistics, or quality management

More important than the formal qualification is the demonstrable competence to correctly implement GDP requirements and to appropriately assess risks.

Particularly relevant practical experience includes:

• Storage and transport of medicinal products
• Handling of temperature-controlled medicinal products
• Supplier and service provider management
• Deviation and CAPA management
• Complaint handling and recall processes

In addition to professional competence, the following personal attributes are essential:

• Assertiveness towards operational departments
• Decision-making capability in situations involving quality risks
• Strong communication skills, particularly at organisational interfaces
• Structured and risk-based thinking
• Integrity and sense of responsibility

The Responsible Person must also be able to set clear quality limits against commercial interests where necessary.

Duties and Responsibilities in Practice

The responsibilities of the GDP Responsible Person are extensive and cover nearly all GDP-relevant processes.

Quality Management System (QMS)

• Establishment, maintenance, and oversight of the GDP Quality Management System
• Approval and implementation of GDP-relevant Standard Operating Procedures (SOPs)
• Ensuring effective implementation in daily operations

Storage and Transport

• Ensuring appropriate storage conditions
• Evaluation and approval of transport concepts
• Oversight and assessment of temperature excursions

Suppliers and Service Providers

• Qualification and monitoring of logistics service providers
• Assessment of outsourced activities
• Approval and review of quality agreements and technical agreements

Deviations, Complaints and Recalls

• Evaluation of GDP deviations
• Definition and follow-up of Corrective and Preventive Actions (CAPA)
• Assessment of returned, falsified, or suspected falsified medicinal products

Training and Self-Inspections

• Ensuring regular GDP training
• Planning and conducting self-inspections
• Preparation for and participation in regulatory inspections

Organisational Requirements

In accordance with the EU GDP Guidelines, the Responsible Person must:

• Have sufficient authority to fulfil the responsibilities
• Operate within clearly defined reporting lines to senior management
• Not be constrained by operational conflicts of interest
• Have sufficient time to perform the assigned duties

A purely nominal designation without actual authority and involvement is not acceptable to competent authorities.

Practical Implementation – Typical Challenges

In practice, the following weaknesses are frequently observed:

• Unclear delineation of responsibilities and authority
• Lack of deputy arrangements
• Insufficient training
• Overburdening due to multiple roles
• Inadequate involvement in strategic decisions

A clearly defined role description and regular assessment of effectiveness are therefore essential to ensure ongoing GDP compliance.

Recommendations for GDP Training

To meet increasing regulatory expectations across the EU, comprehensive and continuous training is essential. Particularly recommended are training courses covering:

• GDP fundamentals and implementation of a GDP Quality Management System
• Temperature management and cold chain control
• Handling of deviations and recalls
• GDP audits and inspection preparedness
• Interfaces between GMP and GDP

Regular professional development is necessary to address evolving regulatory interpretations at both EU and Member State level, as well as emerging supply chain risks. The ECA also offers annual two-day training "The Responsible Person for Good Distribution Practice (GDP)" specifically focused on the tasks and responsibilities. Regular refresher training is necessary in order to adequately address regulatory changes and new risks. One suitable option for this is participation in the annual “GDP Update” webinar.

Working Groups and Further Information

As in other positions of regulatory responsibility, GDP Responsible Persons particularly benefit from professional exchange with peers. Regular dialogue enables the sharing of practical experience and supports the early assessment and interpretation of evolving regulatory expectations at both EU and national level. Examples include participation in professional associations or expert networks dedicated to GDP compliance. For instance, membership in the ECA European GDP Association or attendance at specialised conferences such as the biennial GMP & GDP Forum provide structured opportunities for knowledge exchange. Such platforms offer valuable insight into current inspection trends, competent authority expectations, and regulatory developments. They also support the practical and efficient implementation of new or revised requirements within the wholesale distributor’s Quality Management System.

出處：https://www.gmp-compliance.org/gmp-news/what-requirements-must-a-responsible-person-for-gdp-meet